This edition of the “Market Review” captures critical developments in the Nigerian Capital Market.
It highlighted the following issues:
- Key Decisions from the CMC Q2,2022 Meeting Chaired by SEC DG
- Investor Protection Fund Increase in compensation to retail investors by 100% from N400,000 to N500,000
- Neimeth Pharmaceuticals Plc N3.67bn Rights Issue from August 3rd to 25th, 2022 NGX Equity Trading Report for July 2022 revealing Domestic investors dominated the market by 42% Companies raising Over N100bn through Commercial Papers on the FMDQ Securities Exchange Platform